2010
DOI: 10.1152/jn.00093.2010
|View full text |Cite
|
Sign up to set email alerts
|

Bicuculline-Induced Chorea Manifests in Focal Rather Than Globalized Abnormalities in the Activation of the External and Internal Globus Pallidus

Abstract: Chorea is a basal-ganglia (BG) related hyperkinetic movement disorder characterized by irregular continuous involuntary movements. Chorea and related hyperbehavioral disorders may be induced in behaving primates by local microinjections of the GABA(A) antagonist bicuculline to the globus pallidus externus (GPe). We performed multielectrode extracellular recordings in the GPe and in the globus pallidus internus (GPi) before, during, and after bicuculline microinjections. Bicuculline led to an increase in the fi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 62 publications
(54 reference statements)
1
18
0
Order By: Relevance
“…Selective anatomical and functional abnormalities in the cortico-BG system have been observed in patients suffering from disorders such as Parkinson's disease (Agid, 1991), Huntington's chorea (Glass et al, 2000; Deng et al, 2004), dystonia (Marsden et al, 1985), and motor tics (Singer and Minzer, 2003), which were therefore considered “BG-related movement disorders.” Animal models and anecdotal findings in human patients confirmed that localized dysfunctions (inactivation or disinhibition) of different parts of the BG could directly induce behavioral abnormalities similar to the symptoms observed in these disorders (Martin and Alcock, 1934; Crossman et al, 1988; Hamada and DeLong, 1992; Grabli et al, 2004; Desmurget and Turner, 2008; McCairn et al, 2009; Bronfeld et al, 2010). The exact nature of the abnormal symptoms has been related to the type and location of the BG dysfunction.…”
Section: The Basal Gangliamentioning
confidence: 81%
“…Selective anatomical and functional abnormalities in the cortico-BG system have been observed in patients suffering from disorders such as Parkinson's disease (Agid, 1991), Huntington's chorea (Glass et al, 2000; Deng et al, 2004), dystonia (Marsden et al, 1985), and motor tics (Singer and Minzer, 2003), which were therefore considered “BG-related movement disorders.” Animal models and anecdotal findings in human patients confirmed that localized dysfunctions (inactivation or disinhibition) of different parts of the BG could directly induce behavioral abnormalities similar to the symptoms observed in these disorders (Martin and Alcock, 1934; Crossman et al, 1988; Hamada and DeLong, 1992; Grabli et al, 2004; Desmurget and Turner, 2008; McCairn et al, 2009; Bronfeld et al, 2010). The exact nature of the abnormal symptoms has been related to the type and location of the BG dysfunction.…”
Section: The Basal Gangliamentioning
confidence: 81%
“…(6) The additional hyper-behavioral symptoms (hyperactivity and contraversive circling) which sometimes followed microinjections were common to both species. Such behaviors have been observed in both monkeys (Grabli et al, 2004; Worbe et al, 2009; Bronfeld et al, 2010) and rats (Wisniecki et al, 2003; Ikeda et al, 2010) following microinjections of GABA A antagonists into the striatum or into an adjacent BG nucleus—the GPe. In the current study, hyperbehavioral symptoms were more common following microinjections into the posterior striatum, a location which is closer to the striatum-GPe border, compared with the anterior striatum location.…”
Section: Discussionmentioning
confidence: 96%
“…The critical role of the GP in the control of movement is illustrated by the abnormal activity of GP neurons in movement disorders, including the increased firing rates in the GP in Huntington's disease (Starr et al, 2008) and beta oscillations of the GP neurons in Parkinson's disease (PD) (Mallet et al, 2008). Consistent with the critical role of the GP in basal ganglia circuits and behavior, quinolinic acid lesion of the GP leads to a decrease in spontaneous movement (Hauber et al, 1998) and activation of GP neurons by the microinjection of the GABAA receptor antagonist bicuculline (Matsumura et al, 1995) into the GP induces spontaneous movement (Grabli et al, 2004) and dyskinesia in primates (Crossman et al, 1984; Bronfeld et al, 2010). …”
Section: Introductionmentioning
confidence: 83%